Souleymane Sawadogo
Overview
Explore the profile of Souleymane Sawadogo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
382
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vojnov L, Carmona S, Zeh C, Markby J, Boeras D, Prescott M, et al.
PLoS Med
. 2022 Aug;
19(8):e1004076.
PMID: 35994520
Background: Accurate routine HIV viral load testing is essential for assessing the efficacy of antiretroviral treatment (ART) regimens and the emergence of drug resistance. While the use of plasma specimens...
2.
Sawadogo-Lewis T, Keita Y, Wilson E, Sawadogo S, Terera I, Sangho H, et al.
Glob Health Sci Pract
. 2021 Dec;
9(4):869-880.
PMID: 34933982
Background: Countries with scarce resources need timely and high-quality data on coverage of health interventions to make strategic decisions about where to allocate investments in health. Household survey data are...
3.
Fong Y, Markby J, Andreotti M, Beck I, Bourlet T, Brambilla D, et al.
J Acquir Immune Defic Syndr
. 2021 Nov;
89(3):261-273.
PMID: 34732684
Background: Dried plasma spot specimens may be a viable alternative to traditional liquid plasma in field settings, but the diagnostic accuracy is not well understood. Methods: Standard databases (PubMed and...
4.
Domaoal R, Sleeman K, Sawadogo S, Dzinamarira T, Frans N, Shatumbu S, et al.
J Acquir Immune Defic Syndr
. 2021 Jun;
87(Suppl 1):S67-S72.
PMID: 34166314
Background: In the population-based HIV impact assessment surveys, early infant diagnosis (EID) was provided to infants <18 months without a prior diagnosis. For the Namibia population-based HIV impact assessment (NAMPHIA),...
5.
Agabu A, Baughman A, Fischer-Walker C, de Klerk M, Mutenda N, Rusberg F, et al.
PLoS One
. 2020 Nov;
15(11):e0233341.
PMID: 33170840
Background: Namibia introduced the prevention of mother to child HIV transmission (MTCT) program in 2002 and lifelong antiretroviral therapy (ART) for pregnant women (option B-plus) in 2013. We sought to...
6.
Jordan M, Hamunime N, Bikinesi L, Sawadogo S, Agolory S, Shiningavamwe A, et al.
Medicine (Baltimore)
. 2020 Sep;
99(37):e21661.
PMID: 32925712
To support optimal third-line antiretroviral therapy (ART) selection in Namibia, we investigated the prevalence of HIV drug resistance (HIVDR) at time of failure of second-line ART. A cross-sectional study was...
7.
Implementation and evaluation of a Project ECHO telementoring program for the Namibian HIV workforce
Bikinesi L, OBryan G, Roscoe C, Mekonen T, Shoopala N, Mengistu A, et al.
Hum Resour Health
. 2020 Sep;
18(1):61.
PMID: 32873303
Background: The Namibian Ministry of Health and Social Services (MoHSS) piloted the first HIV Project ECHO (Extension for Community Health Outcomes) in Africa at 10 clinical sites between 2015 and...
8.
Maher A, Nakanyala T, Mutenda N, Banda K, Prybylski D, Wolkon A, et al.
JMIR Public Health Surveill
. 2020 Apr;
6(2):e17107.
PMID: 32348290
Background: Direct measures of HIV incidence are needed to assess the population-level impact of prevention programs but are scarcely available in the subnational epidemic hotspots of sub-Saharan Africa. We created...
9.
Sawadogo S, Shiningavamwe A, Roscoe C, Baughman A, Negussie T, Mutandi G, et al.
Open Forum Infect Dis
. 2018 Dec;
5(2):ofy014.
PMID: 30568984
Three hundred sixty-six adult patients in Namibia with second-line virologic failures were evaluated for human immunodeficiency virus drug-resistant (HIVDR) mutations. Less than half (41.5%) harbored ≥1 HIVDR mutations to standardized...
10.
Agolory S, de Klerk M, Baughman A, Sawadogo S, Mutenda N, Pentikainen N, et al.
Open Forum Infect Dis
. 2018 Sep;
5(9):ofy200.
PMID: 30211248
Background: In 2015, Namibia implemented an Acceleration Plan to address the high burden of HIV (13.0% adult prevalence and 216 311 people living with HIV [PLHIV]) and achieve the UNAIDS...